Frank Butschbacher develops and executes effective investor relations and communications programs for life science companies, from start-up phase to clinical stage to mature corporation.

Our customers benefit from more than 15 years experience in the industry, including private and NASDAQ-listed biotech and Fortune 500 healthcare companies in Europe and the USA.

We secure consistent and relevant international coverage for your company’s news and messages.